Liquidia Corporation - Common Stock — Bilancio Trimestrale (NASDAQ:LQDA) | MetaTrader

Apri il grafico completo Full chart

Notizie

FDA Grants Priority Review to SNY's Filing for Gaucher Disease Drug

Are You Looking for a Top Momentum Pick? Why Liquidia Corporation (LQDA) is a Great Choice

TGTX's Single-Dose Briumvi Hits Bioequivalence Goal in MS Study

CORT to Resubmit NDA for Relacorilant in Cushing's Syndrome, Stock Up

AbbVie Wins FDA Nod for Decnupaz for Rare Blood Cancer Indication

Il titolo azionario di Liquidia Technologies raggiunge il massimo storico a 62,31 USD

Dyne Therapeutics Stock Gains 4.5% After BLA Filing for DMD Therapy

Is it a Good Idea to Invest in Amneal Pharmaceuticals Stock Now?

AGIO's Pyrukynd Gets Approval for Thalassemia in Europe

GILD Scores FDA Win for HDV Drug, CHMP Backs Trodelvy

CHMP Backs EU Approval of Novo Nordisk's Wegovy Pill for Obesity

BDTX Stock Slumps on Mixed Phase II Frontline NSCLC Study Data